Bio-Techne

Bio-Techne - Where Science Intersects Innovation.

Launch date

1981

Employees

1001-5000 people

Market cap

Net debt

($350m)

Enterprise valuation

$11.7b (Public information from Jun 2024)

Minneapolis Minnesota (HQ)

http://bio-techne.com

https://twitter.com/biotechne https://www.facebook.com/biotechne https://www.linkedin.com/company/bio-techne

View job openings

Deals in current and previous year:

Revenues, earnings & profits over time

USD	2019	2020	2021	2022	2023	2024	2025
Revenues	0000	0000	0000	0000	0000	0000	0000
% growth	11 %	3 %	26 %	19 %	3 %	1 %	8 %
EBITDA	0000	0000	0000	0000	0000	0000	0000
% EBITDA margin	30 %	21 %	25 %	36 %	36 %	-	-
Profit	0000	0000	0000	0000	0000	0000	0000
% profit margin	13 %	31 %	15 %	25 %	25 %	-	-
EV / revenue	00.0x	00.0x	00.0x	00.0x	00.0x	00.0x	00.0x
EV / EBITDA	00.0x	00.0x	00.0x	00.0x	00.0x	00.0x	00.0x
R&D budget	0000	0000	0000	0000	0000	0000	0000
R&D % of revenue	9 %	9 %	8 %	8 %	8 %	-	-

Get premium to view all results

Date	Investors	Amount	Round
-	investor	$0.0	round
May 1989	N/A	$0.0	round
Dec 2023*	Manulife Financial	$12.0m	Post IPO Equity
Total Funding		000k

Tech stackLearn more about the technologies and tools that this company uses.

By Country

United States 12 China 2 Switzerland 1

By Industry

Health 11 Enterprise Software 1 Marketing 1

By Round

ACQUISITION 11 EARLY VC 2 LATE VC 2 SERIES C 1

Lunaphore Technologies

ACQUISITION by Bio-Techne Jun 2023

Zephyrus Biosciences

ACQUISITION by Bio-Techne Mar 2016

ACQUISITION by BioMérieux Apr 2018

ACQUISITION by Amgen Aug 2022

Advanced Cell Diagnostics

ACQUISITION by Bio-Techne Jul 2016

ACQUISITION by Bio-Techne Jun 2013

ACQUISITION by Bio-Techne Nov 2014

ACQUISITION by Bio-Techne Jun 2022

Novus Biologicals

ACQUISITION by Bio-Techne Jul 2014

Quad Technologies

ACQUISITION by Bio-Techne Jun 2018